Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 3/20 | 0.49 |
| ▸ | PLK1 | P53350 | 3/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | THRA | P10827 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | RARB | P10826 | 1/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | XDH | P47989 | 1/20 | 0.40 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11258895 | 0.90 | HCAR3 (0.47) | HCAR3PLK1EPHX2THRATHRB | |
| SCHEMBL11255414 | 0.88 | HCAR3 (0.62) | HCAR3PLK1EPHX2THRBRARB | |
| SCHEMBL15412525 | 0.88 | HCAR3 (0.62) | HCAR3PLK1EPHX2THRBRARB | |
| SCHEMBL11262794 | 0.86 | HCAR3 (0.61) | HCAR3PLK1EPHX2THRBRARB | |
| SCHEMBL11270514 | 0.85 | PLK1 (0.43) | HCAR3PLK1EPHX2THRATHRB | |
| SCHEMBL11258316 | 0.85 | HCAR3 (0.49) | HCAR3PLK1EPHX2RARBNAAA | |
| SCHEMBL11262791 | 0.83 | HCAR3 (0.50) | HCAR3PLK1EPHX2RARBNAAA | |
| Hydrochloric Acid SCHEMBL11250653 | 0.83 | HCAR3 (0.47) | HCAR3PLK1EPHX2RARBCNR2 | |
| SCHEMBL11258578 | 0.83 | MAPT (0.55) | HCAR3PLK1EPHX2 | |
| SCHEMBL11260606 | 0.83 | ALDH1A1 (0.50) | HCAR3PLK1EPHX2THRATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4333940-A | Ring-fluorinated 4-(monosubstituted-amino) phenyl compounds in inhibiting atherosclerotic lesion development | AMERICAN CYANAMID COMPANY (US) | 1982-06-08 | — | — | US | disclosed |
| US-4243609-A | ANTILIPEMIC AGENTS, ANTIATHEROSCLEROTIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1981-01-06 | — | — | US | disclosed |
| EP-0003663-A2 | Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them | AMERICAN CYANAMID COMPANY (US) | 1979-08-22 | — | — | EP | disclosed |